Your browser doesn't support javascript.
loading
Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting.
Angst, Daniel C; Tepekule, Burcu; Sun, Lei; Bogos, Balázs; Bonhoeffer, Sebastian.
Afiliação
  • Angst DC; Institute of Integrative Biology, Department for Environmental System Science, ETH Zurich, 8092 Zurich, Switzerland daniel.angst@env.ethz.ch.
  • Tepekule B; Institute of Integrative Biology, Department for Environmental System Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Sun L; Institute of Integrative Biology, Department for Environmental System Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Bogos B; Institute of Integrative Biology, Department for Environmental System Science, ETH Zurich, 8092 Zurich, Switzerland.
  • Bonhoeffer S; Institute of Integrative Biology, Department for Environmental System Science, ETH Zurich, 8092 Zurich, Switzerland.
Proc Natl Acad Sci U S A ; 118(13)2021 03 30.
Article em En | MEDLINE | ID: mdl-33766914
ABSTRACT
The rapid rise of antibiotic resistance, combined with the increasing cost and difficulties to develop new antibiotics, calls for treatment strategies that enable more sustainable antibiotic use. The development of such strategies, however, is impeded by the lack of suitable experimental approaches that allow testing their effects under realistic epidemiological conditions. Here, we present an approach to compare the effect of alternative multidrug treatment strategies in vitro using a robotic liquid-handling platform. We use this framework to study resistance evolution and spread implementing epidemiological population dynamics for treatment, transmission, and patient admission and discharge, as may be observed in hospitals. We perform massively parallel experimental evolution over up to 40 d and complement this with a computational model to infer the underlying population-dynamical parameters. We find that in our study, combination therapy outperforms monotherapies, as well as cycling and mixing, in minimizing resistance evolution and maximizing uninfecteds, as long as there is no influx of double resistance into the focal treated community.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Evolução Molecular / Farmacorresistência Bacteriana / Quimioterapia Combinada / Epidemias / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Evolução Molecular / Farmacorresistência Bacteriana / Quimioterapia Combinada / Epidemias / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article